Position
Chief Medical Officer
Company
Jade Biosciences
WalthamInformation TechnologyBiotechnologyHealthcareHealth CareTherapeuticsDescription
Jade Biosciences has appointed Edward R. Conner, M.D. as Chief Medical Officer, effective April 22, 2026
Quick answer
Jade Biosciences Appoints Edward R. Conner, M.D. as Chief Medical Officer (April 23, 2026). Jade Biosciences is based in Waltham, Massachusetts, United States.
- Who is the new Chief Medical Officer at Jade Biosciences?
- Jade Biosciences named Edward R. Conner, M.D. Chief Medical Officer, announced April 23, 2026.
- What did Jade Biosciences announce on April 23, 2026?
- Jade Biosciences has appointed Edward R. Conner, M.D. as Chief Medical Officer, effective April 22, 2026
- What does Jade Biosciences do?
- Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases.
- Where is Jade Biosciences based?
- Jade Biosciences is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Pelthos Therapeutics (April 10, 2026), Rhythm Pharmaceuticals (April 3, 2026), Recursion Pharmaceuticals (March 25, 2026) and TuHURA Biosciences (March 23, 2026) also announced leadership changes within 45 days of Jade Biosciences.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pelthos Therapeutics Appoints John M. Gay as Chief Financial Officer (April 10, 2026)
- Kimberly J. Popovits Appointed as Non-Employee Director of Rhythm Pharmaceuticals (April 3, 2026)
- Recursion Pharmaceuticals Appoints Vicki Goodman, M.D., as Chief Medical Officer (March 25, 2026)
- TuHURA Biosciences Appoints Dr. Craig L. Tendler as Chief Medical Officer (March 23, 2026)
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
Who to call at Jade Biosciences, and when
A new leader at Jade Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Jade Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jade Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Jade Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Jade Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Jade Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.